Host genomics and HCV treatment response

Grants

Funding Acknowledgements

AJT has received research support from Merck, Roche, and Gilead Sciences; has served as a consultant for Merck, Roche and Janssen-Cilag; and has served on a speaker bureau for Merck. PJC has received funding support from the Duke Clinical Research Institute, the Richard Boebel Family Fund, the National Health and Medical Research Council of Australia (APP1017139), and the Gastroenterological Society of Australia. AJT has received funding from the National Health and Medical Research Council of Australia (APP567057). PJC has received funding from the National Centre in HIV Epidemiology and Clinical Research (now The Kirby Institute for Infection and Immunity in Society), University of New South Wales, and the AASLD/LIFER Clinical and Translational Research Fellowship in Liver Diseases Award.